Evidence map›Paper›PMID 24652288›Full record

ArticleThe Journal of biological chemistry2014

Regulation of fibroblast growth factor-inducible 14 (Fn14) expression levels via ligand-independent lysosomal degradation.

Sujatha Gurunathan, Jeffrey A Winkles, Sankar Ghosh, Matthew S Hayden

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Fn14-Targeted Gold Nanorods for Augmenting Laser Thermal Therapy for High-Grade Gliomas.Langmuir : the ACS journal of surfaces and colloids · 2025
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Tumor-targeted nanotherapeutics: overcoming treatment barriers for glioblastoma.Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology · 2017
    Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Sujatha GurunathanFrom the Departments of Microbiology and Immunology and.
Jeffrey A Winkles
Sankar Ghosh
Matthew S Hayden
Columbia University · USUniversity of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center

Funding

Understanding the Biology of Chronic Ulcers: Histological and Molecular Basis...P30AR044535 · NIAMS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI BICKERS, DAVID RINSEY · 1997 to 2015
$6.9M
Regulation of NF-kB and IkB ProteinsR37AI033443 · NIAID · YALE UNIVERSITY · PI GHOSH, SANKAR · 2001 to 2010
$3.4M
The Fn14 Receptor and Brain Tumor InvasionR01NS055126 · NINDS · UNIVERSITY OF MARYLAND BALTIMORE · PI WINKLES, JEFFREY A · 2007 to 2011
$1.6M
Biomedical Research Core Center on Skin Stem CellsP30AR058886 · NIAMS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI BICKERS, DAVID RINSEY · 2009 to 2010
$1.5M
TWEAK-Fn14 Signaling in the Tumor MicroenvironmentR01CA130967 · NCI · UNIVERSITY OF MARYLAND BALTIMORE · PI WINKLES, JEFFREY A · 2009 to 2012
$1.2M
NCI NIH HHS R01 CA130967NIAID NIH HHS R37 AI033443NIAID NIH HHS R37 AI33443NIAMS NIH HHS P30 AR044535NIAMS NIH HHS P30 AR058886NINDS NIH HHS R01 NS055126
6 · The paper itself

Abstract

Fibroblast growth factor-inducible 14 (Fn14) is a highly inducible cytokine receptor that engages multiple intracellular signaling pathways, including nuclear factor-κB (NF-κB) and mitogen-activated protein kinase (MAPK). Fn14 expression is regulated by several cytokines and growth factors, and Fn14 is transiently up-regulated after injury. In contrast, in states of chronic inflammatory disease and in some solid tumors, Fn14 is persistently up-regulated. However, the post-translational regulation of Fn14 expression has not been directly investigated. Thus, we examined Fn14 proteostasis in the presence and absence of the Fn14 ligand TNF-like weak inducer of apoptosis (TWEAK). Similar to other TNF receptor superfamily members, we found that TWEAK induces Fn14 internalization and degradation. Surprisingly, we also observed rapid, TWEAK-independent, constitutive Fn14 internalization and turnover. Fn14 levels are maintained in cell culture by ongoing synthesis and trafficking of the receptor, leading to subsequent down-regulation by lysosomal degradation. Unexpectedly, the extracellular domain of Fn14 is necessary and sufficient for constitutive turnover. Based on these findings, we propose a model in which constitutive down-regulation of Fn14 facilitates dynamic regulation of Fn14 protein levels and prevents spontaneous or inappropriate receptor signaling.

Indexed as

ProteolysisAnimalsCytokine TWEAKGene Expression RegulationHEK293 CellsHeLa CellsHumansLysosomesMiceMice, KnockoutProtein TransportReceptors, Tumor Necrosis FactorSignal TransductionTumor Necrosis FactorsTWEAK ReceptorCytokine TWEAKReceptors, Tumor Necrosis FactorTNFRSF12A protein, humanTnfrsf12a protein, mouseTNFSF12 protein, humanTnfsf12 protein, mouseTumor Necrosis FactorsTWEAK ReceptorFn14InflammationProteostasisReceptor EndocytosisReceptor RegulationTraffickingTumor Necrosis Factor (TNF)Tweak

Identifiers

PMID24652288
PMCPMC4036313
OpenAlexW1968134260

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.